Nyxoah S.A.
WHO'M
ai
Digital Profiler. Simply click the AI button
FIGI: BBG00X7DCB76
NYXH
Nyxoah S.A.
GICS: -
·
Sector: -
·
Sub-Sector: -
NAME
Nyxoah S.A.
ISIN
BE0974358906
TICKER
NYXH
MIC
XBRU
REUTERS
NYXH.BR
BLOOMBERG
NYXH BB
Financial Intelligence
FOR INVESTORS
FOR TRADERS
Securities Trading
Warrants
EQS Newswire is a major provider of regulatory and corporate news. It mainly serves companies, investors and media worldwide. Through its services, EQS Newswire enables efficient and secure communication between companies and their stakeholders. Its main services include the distribution of ad hoc announcements, corporate news and the publication of financial reports that meet strict international standards.
Fri, 27.09.2024
DREAM Pivotal Study Data Presented at the International Surgical Sleep Society 2024 Educational Update
Additional clinical data on patients suffering from Obstructive Sleep Apnea (OSA) demonstrate a clinically significant 71.0% median reduction in Apnea-Hypopnea index (AHI) while sleeping supine at 12 months compared with baseline.
82.0% of patie...
Mon, 02.09.2024
Nyxoah Rings the Closing Bell at Nasdaq while Preparing for U.S. Market Launch of Innovative Sleep Apnea Device
FDA regulatory submission for the Company’s Genio® device is complete, U.S. approval on track for the end of 2024
U.S. commercial launch, expected at the beginning of 2025, fully funded with over €85 million in new capital raised
Mont...
Tue, 06.08.2024
Nyxoah Reports Second Quarter and First Half 2024 Financial and Operating Results
FDA regulatory submission complete, U.S. approval on track for end of 2024
U.S. commercial launch fully funded with over €85 million in new capital raised
Mont-Saint-Guibert, Belgium – August 6, 2024 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NY...
Mon, 15.07.2024
Nyxoah Appoints Scott Holstine as Chief Commercial Officer
Mont-Saint-Guibert, Belgium – July 15, 2024, 8:00am CET / 2:00am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today ...
Wed, 03.07.2024
Nyxoah Has Signed a €37.5 Million Loan Facility Agreement with the European Investment Bank
Mont-Saint-Guibert, Belgium – July 3, 2024, 12:30pm CET / 6:30am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obst...
Information on product placements
